비소세포성폐암 환자의 Monototal™ 유용성 평가

Evaluation of Usefulness for Monototal™ in Non Small Cell Lung Cancer

Purpose: Cancerous death rate 1 place from 2008 year domestic is the lung cancer. The body count which is caused by in the lung cancer every year is increasing. At this lung cancer is the most non small cell lung cancer. Monototal™ test is short reaction time. it is known as the experiment where the example standard of living is high about non small cell lung cancer. This is the study evaluate usefulness of Monototal™ kit. Materials and Methods: Monototal™ were measured using IRMA kit, using 40 CEA positive patients sample which are diagnosed NSCLC, 15 SCC positive patients sample which are diagnosed NSCLC, 40 Cyfra 21-1 positive sample, 20 negative sample in Seoul national university from March to April, 2009. Results: According to result of the Monototal™ test , which is benignancy rate 87.5% in CEA positive patients sample, 93.3% SCC positive patients sample and 100% Cyfra 21-1 positive sample Conclusions: We recommend that using of Monototal™ parallel with different tumor markers. It was useful that diagnosis and convalescence presumption of Non small cell lung cancer.